Compound Monograph

Hericene A

Hericene A is a fruiting-body aromatic (hericerin derivative) of lion's mane (Hericium erinaceus), distinct from the better-known hericenones and erinacines. Its notable finding is a single 2023 study showing pan-neurotrophic, ERK1/2-convergent neurite-outgrowth activity and improved spatial memory in mice — reported as BDNF-independent. No human, clinical or pharmacokinetic data exist for the isolate.

Where Does It Come From? (1)

Hericene A is a naturally occurring hericerin derivative (aromatic), found in Lion's Mane. It is well tolerated orally (low toxicity).

Pharmacology & Research

Hericene A is an aromatic hericerin derivative (of the isohericerin family) found in the fruiting body of lion’s mane (Hericium erinaceus). It is a distinct, less-studied molecule from the two better-known neuroactive groups of the mushroom: the hericenones (fruiting-body NGF-synthesis stimulators) and the erinacines (mycelium-specific cyathane diterpenoids). Its entire notable profile rests on essentially one study — a 2023 report that hericene A drives a neurotrophic response and improves memory in mice — and the load-bearing caveat is that lion’s mane’s human cognitive data (small trials in mild cognitive impairment) belongs to the whole extract/mycelium, not to this isolated constituent.

What the evidence supports
  • A single-study neurotrophic signal: hericene A promoted potent neurite outgrowth and a pan-neurotrophic response in hippocampal neurons converging on ERK1/2, and a hericene-A-containing extract improved recognition/spatial memory in mice 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.
  • A distinctive mechanistic note: the effect was reported BDNF-independent — neurotrophic-pathway activity distinct from classical BDNF/TrkB ligand signalling, and different from the hericenones’ NGF-synthesis route 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.
  • The honest headline: one research group, one publication; no replication, no human isolate data, no pharmacokinetics — and the memory readout used a whole extract, not the purified compound 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.
Evidence by indicationStrength of support
1. Neurotrophic / cognitive

The distinctive finding, and the reason the page exists. Hericene A (and its analogue N-dephenylethyl isohericerin) promoted potent neurite outgrowth and a pan-neurotrophic response in cultured hippocampal neurons, converging on ERK1/2 signalling, and a hericene-A-containing H. erinaceus extract improved recognition/spatial memory in mice — notably via a BDNF-independent mechanism, distinct from the hericenones’ NGF-synthesis stimulation 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.

Gap: a single research group and single publication, with no independent replication, no dose-response and no isolated-compound human data; the “improved memory” readout used a whole extract, not the purified isolate 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.

2. Neuroprotective (inferred)

Neurotrophic signalling is mechanistically adjacent to neuroprotection, and lion’s-mane fruiting-body aromatics are broadly described as neuroprotective, but no hericene-A-specific neuroprotection endpoint (e.g. against a toxin or ischaemia model) has been shown 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.

Gap: this is extrapolation from the neurotrophic finding and the parent herb’s reputation, not direct hericene-A data — it should not be overstated 1Reference 1Martínez-Mármol R et al. · 2023Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memoryView study →.

Mechanisms

Target / pathwayEffectRelevant to
Pan-neurotrophic signalling → ERK1/2 (MAPK)activation; drives neurite outgrowth in hippocampal neuronsneurotrophic / cognitive
Neurotrophic response — BDNF-independentpathway activation without requiring BDNF; distinct from canonical BDNF/TrkB ligand actionneurotrophic / cognitive
Neurite outgrowth / memory↑ length and branching in vitro; behavioural memory improvement in mice (whole extract)cognitive / memory

Honest mechanism note: the verified finding centres on a pan-neurotrophic pathway convergent on ERK1/2 and is explicitly BDNF-independent — describe it that way rather than asserting a clean canonical TrkB-BDNF agonism. Contrast with the hericenones (NGF-synthesis stimulation) and erinacines (NGF-stimulating cyathane diterpenoids).

Pharmacokinetics

There is no data. No absorption, distribution, metabolism, excretion, bioavailability or brain-penetration parameter has been measured for isolated hericene A in any species. The mouse memory readout used an oral whole extract — implying some functionally relevant CNS exposure — but no PK parameters were determined.

Clinical trials

There are no human trials of hericene A. Small human cognitive trials of lion’s mane (e.g. in mild cognitive impairment, and an erinacine-A-enriched mycelium pilot in mild Alzheimer’s) used whole fruiting-body extract or mycelium, not hericene A — those results cannot be attributed to this constituent.

CompletedPlannedTerminatedPreclinical
(none, isolate)Thin(one study)

Last checked: July 2026.

Toxicity & Safety

Hericene A carries a low flag by origin: it occurs in Hericium erinaceus, a widely consumed edible mushroom with a long dietary history and good general tolerability. However, the purified isolate has never undergone toxicology — no LD50, genotoxicity or organ-toxicity data — so the low rating reflects the whole-food context, not isolate-specific testing. Rare idiosyncratic dermatitis/respiratory hypersensitivity is reported for lion’s-mane whole products.

Pregnancy & lactation

Lion’s mane as an ordinary culinary food is presumed low-risk in normal dietary amounts, but the isolated/concentrated compound is untested — avoid concentrated isolate or high-dose neurotrophic-marketed extracts in pregnancy and lactation. This is precautionary; no reproductive-toxicity data exist for the isolate.

Dosage

There is no established dose for hericene A. No human or defined preclinical dose exists for the isolate, and content in fruiting-body products varies widely with strain, substrate and extraction and is not standardised. Any dosing guidance should reference whole lion’s-mane extract, not this constituent.

References

  1. Martínez-Mármol R, et al. (2023). Hericerin derivatives activate a pan-neurotrophic pathway in central hippocampal neurons converging on ERK1/2 signalling to enhance spatial memory. Journal of Neurochemistry. https://pubmed.ncbi.nlm.nih.gov/36660878/